Skip to content

The consistency study of EORTC QLQ-LC43 scale and SF-36 scale in evaluating the quality of life in patients with advanced lung cancer

The consistency study of EORTC QLQ-LC43 scale and SF-36 scale in evaluating the quality of life in patients with advanced lung cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071434
Enrollment
Unknown
Registered
2023-05-15
Start date
2020-08-05
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Sponsors

The Second Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
43 Years to 67 Years

Inclusion criteria

Inclusion criteria: All included patients must meet the diagnostic criteria for primary bronchogenic lung cancer; Confirmed by pathological diagnosis; Age 18-75 years old; The expected survival period is more than 5 months; And voluntarily accept the investigation. There is no limit to tumor staging, patient ethnicity, cultural level, and treatment methods.

Exclusion criteria

Exclusion criteria: Those who are accompanied by serious complications and serious systemic diseases and need special treatment, who have mental system diseases, language communication disorders, pulmonary tuberculosis and other infectious diseases, have poor compliance and cannot cooperate with follow-up researchers.

Design outcomes

Primary

MeasureTime frame
Questionnaire Score;

Countries

China

Contacts

Public ContactSu Xiaoning

The Second Affiliated Hospital of Fujian Medical University

suxn_1983@163.com+86 136 3697 9858

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026